AJJ Medtech Holdings Limited (584.SI)
- Previous Close
0.0040 - Open
0.0040 - Bid 0.0040 x --
- Ask 0.0050 x --
- Day's Range
0.0040 - 0.0040 - 52 Week Range
0.0040 - 0.0080 - Volume
39,500 - Avg. Volume
738,354 - Market Cap (intraday)
5.508M - Beta (5Y Monthly) 0.68
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date Feb 29, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date Apr 30, 2014
- 1y Target Est
--
AJJ Medtech Holdings Limited provides providing MedTech integrated solutions to healthcare sector in Singapore. It supplies medical devices with complementary digital, artificial intelligence (AI), and robotics solutions to customers and supplying partners. The company offers in-vitro diagnostics, including point of call diagnostics with focus on at-home monitoring and diagnostics, including blood glucose monitoring system and single-use test kits, as well as laboratory diagnostics and biobanking solutions with focus on solutions on diagnostics and academic research. The company also provides clinical stage cancer treatment device, including high-intensity focused ultrasound (HIFU), general and plastic surgery devices, and ward-side consumables. In addition, it distributes Samsung Medison ultrasound products; and dental supplies and intra-oralscanners, as well as provides management consultancy services for healthcare organizations. The company was formerly known as OEL (Holdings) Limited and changed its name to AJJ Medtech Holdings Limited in February 2024. AJJ Medtech Holdings Limited was incorporated in 1984 and is based in Singapore.
www.ajjmedtech.com.sgRelated News
Performance Overview: 584.SI
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 584.SI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 584.SI
Valuation Measures
Market Cap
5.51M
Enterprise Value
7.79M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.31
Price/Book (mrq)
--
Enterprise Value/Revenue
4.82
Enterprise Value/EBITDA
-3.78
Financial Highlights
Profitability and Income Statement
Profit Margin
-156.47%
Return on Assets (ttm)
-49.10%
Return on Equity (ttm)
--
Revenue (ttm)
1.61M
Net Income Avi to Common (ttm)
-2.56M
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
409k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-826.5k
Company Insights: 584.SI
584.SI does not have Company Insights